n-fluoroacetyl-d-glucosamine has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Fujiwara, T; Fukuda, H; Itoh, M; Iwata, R; Kubota, K; Sato, K; Sato, T; Tada, M; Takahashi, J | 1 |
| Fujiwara, T; Fukuda, H; Hatazawa, J; Itoh, M; Iwata, R; Kubota, K; Matsuzawa, T; Sato, K; Sato, T; Tada, M | 1 |
2 other study(ies) available for n-fluoroacetyl-d-glucosamine and Experimental Hepatoma
| Article | Year |
|---|---|
N-(F-18)-fluoroacetyl-D-glucosamine: a new positron labeled pharmaceutical for cancer study.
Topics: Acetylgalactosamine; Acetylglucosamine; Animals; Fluorine Radioisotopes; Hexosamines; Liver Neoplasms, Experimental; Male; Mannose; Rats; Rats, Inbred Strains; Tissue Distribution | 1992 |
N-[18F]fluoroacetyl-D-glucosamine: a potential agent for cancer diagnosis.
Topics: Acetylglucosamine; Animals; Autoradiography; Fluorine Radioisotopes; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Rabbits; Tissue Distribution; Tomography, Emission-Computed | 1990 |